Measuring the burden of opioid-related mortality in Ontario, Canada
Gomes T, Greaves S, Tadrous M, Mamdani MM, Paterson JM, Juurlink DN. J Addict Med. 2018; 12(5):418-9. Epub 2018 Apr 25.
Publications
Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program
Tadrous M, Greaves S, Martins D, Mamdani MM, Juurlink DN, Gomes T. CMAJ Open. 2018; 6(1):E132-8. Epub 2018 Mar 26.
Risk of intracranial hemorrhage after carotid artery stenting versus endarterectomy: a population-based study
Hussain MA, Alali AS, Mamdani M, Tu JV, Saposnik G, Salata K, Nathens AB, de Mestral C, Bhatt DL, Verma S, Al-Omran M. J Neurosurg. 2018; 129(6):1522-9. Epub 2018 Feb 2.
Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: an ecologic study
Tadrous M, Elterman D, Khuu W, Mamdani MM, Juurlink DN, Gomes T. Can Urol Assoc J. 2018; 12(3):E142-5. Epub 2017 Dec 22.
Improvements in osteoporosis testing and care are found following the wide scale implementation of the Ontario Fracture Clinic Screening Program: an interrupted time series analysis
Beaton DE, Mamdani M, Zheng H, Jaglal S, Cadarette SM, Bogoch ER, Sale JEM, Sujic R, Jain R. Medicine. 2017; 96(48):e9012.
Prior authorization and Canadian public utilization of direct-acting oral anticoagulants
Gao L, Tadrous M, Knowles S, Mamdani M, Paterson JM, Juurlink D, Gomes T. Healthc Policy. 2017; 13(2):68-78.
Real-world healthcare utilization and effectiveness of omalizumab for the treatment of severe asthma
Tadrous M, Khuu W, Lebovic G, Stanbrook MB, Martins D, Paterson JM, Mamdani MM, Juurlink DN, Gomes T. Ann Allergy Asthma Immunol. 2018; 120(1):59-65.e2. Epub 2017 Oct 3.
Gabapentin, opioids and the risk of opioid-related death: a population-based nested case-control study
Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. PLoS Med. 2017; 14(10):e1002396. Epub 2017 Oct 3.
Effectiveness of a financial incentive to physicians for timely follow-up after hospital discharge: a population-based time series analysis
Lapointe-Shaw L, Mamdani M, Luo J, Austin PC, Ivers NM, Redelmeier DA, Bell CM. CMAJ. 2017; 189(39):E1224-9. Epub 2017 Oct 2.
Prevalence and characteristics of opioid-related deaths involving alcohol in Ontario, Canada
Gomes T, Juurlink DN, Mamdani MM, Paterson JM, van den Brink W. Drug Alcohol Depend. 2017; 179:416-23. Epub 2017 Aug 31.